Compounds of formula (I) ##STR00001## as well as pharmaceutically acceptable salts and esters thereof, wherein R.sup.1 to R.sup.7 have the significances given in the description and claims can be used in the form of pharmaceutical compositions.

 
Web www.patentalert.com

< EP.sub.4 receptor antagonists

> 5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes

> Fused heterocyclic derivatives as PPAR modulators

~ 00514